External reports (aggregated public sources), Value Investors Club

Value Investors Club (VIC)

Value Investors Club (.com) is an exclusive online investment club where top investors share their best ideas. Content available at the above link/PDF preview is an external article authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External reports (aggregated public sources)

Value Investors Club

Equity Bottom-Up

<ul><li>Gossamer Bio is developing seralutinib for PAH in Phase 3 clinical trials</li><li>Recent changes in C-suite, insider stock purchases, and partnerships with pharmaceutical companies</li><li>Company has ample cash and near-term catalysts for high upside potential in treating PAH, a serious hemodynamic disorder.</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Gossamer Bio is developing seralutinib for PAH in Phase 3 clinical trialsRecent changes in C-suite, insider stock purchases, and partnerships with pharmaceutical companiesCompany has ample cash and near-term catalysts for high upside potential in treating PAH, a serious hemodynamic disorder.This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Gossamer Bio Inc (GOSS) - Monday, Aug 26, 2024